A group of members of Congress is demanding the U.S. Postal Service explain a memo it recently issued warning newspapers not to mail any publications containing advertisements for marijuana.

“It appears a clarification of USPS policy is needed for state-legal marijuana businesses who seek to mail advertisements, as well as newspapers or periodicals that may run ads from marijuana businesses and who rely on the Postal Service to distribute their publications,” the lawmakers wrote in a letter on Thursday.

Remember WWE star Val “Helloooooo, ladies!” Venis? Yeah, you do. He spent about a decade playing the role of a “former porn star” and making appearances in little more than a towel. He was also a big weed advocate during his final days with the company and, after leaving, said he’d never return to the WWE if they didn’t stop testing wrestlers for weed. If you somehow don’t remember him, we’ve included his first promo (NSFW alert!) in the clip above.

Hemp Inc (OTCMKTS:HEMP) recently made a parabolic move up after a bill that would make Industrial hemp legal in North Carolina was not vetoed by Governor Pat McCrory meaning it will now be passed into law. This was big news for HEMP which recently announced the purchase of a 70,000 square foot hemp processing plant and decortication line of equipment in Spring Hope, North Carolina.

HEMP has been trading on the bb’s and has been a great barometer of the pot sector in the past making several spectacular moves up both in early 2013 and again in 2014. Currently trading at the bottom of its range Investors are hoping for another breakout.

Curaleaf said it can provide New York with medical marijuana 'tomorrow'

Weed on the web isn't unheard of. The issue may still be touchy for some, but the ways in which you can get legal marijuana are emerging faster than ever before. Even big wigs from major tech companies are looking at ways to capitalize on the growing popularity of the feel-good substance, and at least one group within the 420-friendly business is making its approval and distribution process both simpler and cheaper for applicants.

Around the globe there is high interest in the use of cannabidiol (CBD), a type of cannabinoid, for the treatment of people with epilepsy, especially children who have treatment-resistant forms of the disorder such as Lennox-Gastaut Syndrome (LGS) and Dravet Syndrome (DS). Three studies presented at the American Epilepsy Society’s 69th Annual Meeting in Philadelphia highlight emerging efficacy and safety data of Epidiolex, a pharmaceutical liquid formulation of cannabidiol, which is currently undergoing U.S. Food and Drug Administration (FDA) authorized Phase 3 pivotal clinical trials in the United States and across the globe by GW Pharmaceuticals. A fourth study highlights possible interactions of CBD with existing anti-epileptic drugs (AEDs) in animal models of seizures.

Rob Kampia thinks so, and he’s a very well-placed observer. As head of the Marijuana Policy Project, Kampia has his finger on the pulse of pot politics as well as anyone, and he made a pretty startling prediction at the International Drug Reform Conference in suburban Washington last weekend.

At a panel on “Marijuana Reform in Congress,” Kampia suggested that a handful of state-level marijuana legalization victories next year is going to set in motion a congressional debate on legalization that could see an end to federal marijuana prohibition before the end of the decade.

When AJ Gentile, his wife Jennifer and his brother Gene started making marijuana-infused gummy bears in 2011, the cannabis laws of California were more like guidelines than detailed regulations. “We did everything by the book,” said AJ, “but we were always worried a squad in blue FBI or DEA windbreakers would burst through the door to put us out of business and throw us in jail.”

This new study out of London may shift the benefits-versus-risk profile of marijuana in the wrong direction.

For all intents and purposes marijuana legalization has been a practically unstoppable force for the better part of two decades.

Marijuana's tug of war with Congress
Although we've witnessed a couple of rare defeats -- such as Florida's failed medical marijuana amendment in 2014, which missed out on a passing vote by just 2%, and Ohio's Issue 3, which was steamrolled in last month's elections -- marijuana's influence and the public's perception of the drug have grown at a remarkable pace.